Principales conclusions et analyse des parts de marché de l'ivermectine d'ici 2025-2031
Ivermectin Medication Market Report Analysis
Ivermectin Medication Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- Intas Pharmaceuticals
- Boehringer Ingelheim International GmbH
- Cipla, Inc.
- Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
- Sun Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Bayer AG
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Voie d'administration
- orale
- injecteur
By Indication
- onchocercose
- ascaridiase
- strongyloïdose
- parasitose intestinale
- filariose lymphatique
- autres
By Application
- usage humain
- usage vétérinaire
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For